Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the CRISPR-Based Diagnostics Market?

In recent times, the market size of CRISPR-based diagnostics has witnessed a significant expansion. The market, worth $4.35 billion in 2024, is predicted to increase to $5.14 billion in 2025, implying an 18.1% compound annual growth rate (CAGR). Factors contributing to the growth include increased health care spending, escalated demand for gene-editing technologies, a surge in chronic disease cases, greater awareness about available treatments, and a rise in genetic disease prevalence.

What Growth Rate Is Forecasted for the CRISPR-Based Diagnostics Market by 2029?

In the foreseeable future, the CRISPR-based diagnostics market is projected to experience an accelerated growth, culminating in a valuation of $9.92 billion by 2029, with a compound annual growth rate (CAGR) of 17.9%. The upswing in the projected period can be linked to increasing needs for quick and precise diagnostics, an escalating number of uses in pinpointing infectious diseases, funding from government and institutions, enhanced identification of antibiotic resistance, and a surge in recognition and reception of CRISPR technologies. Pivotal trends in the predicted timeframe encompass point-of-care (POC) testing, the CRISPR-Cas12 and Cas13 systems, personalized treatments and genetic examinations, amalgamation with nanotechnology and biosensors, and early diagnosis of diseases using CRISPR.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20734&type=smp

Which Key Companies Are Shaping the Future of the CRISPR-Based Diagnostics Market?

Major companies operating in the CRISPR-based diagnostics market are Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., Molbio Diagnostics, Horizon Discovery, Beam Therapeutics, Intellia Therapeutics Inc., Synthego Corporation, Caribou Biosciences, Mammoth Biosciences, Verve Therapeutics, Editas Medicine, Epic Bio, Sherlock Biosciences, Addgene, VedaBio, CrisprBits, SNIPR BIOME ApS, TOLO Biotech, Intact Genomics, Agdia Inc., ToolGen Inc.

Which Factors Are Driving Demand in the CRISPR-Based Diagnostics Industry?

The escalation of infectious diseases is predicted to spur the growth of the CRISPR-based diagnostics market. Illnesses caused by pathogenic microorganisms like bacteria, viruses, fungi, or parasites which have the ability to spread directly or indirectly from individuals, via infected surfaces, food, water or insects, are referred to as infectious diseases. Factors contributing to their escalated incidence include globalization, antibiotic resistance, climate change, urbanization, population growth, destruction of habitats, and inadequate healthcare access. The effectiveness of combating infectious diseases is ameliorated by CRISPR-based diagnostics, as they provide rapid and precise pathogen detection, leading to early diagnosis, swift intervention and improved containment measures. As an illustration, a UK-based executive agency called UK Health Security Agency, in England, reported in August 2024 that there were 368 incidents of measles in 2023, exhibiting a nearly sevenfold surge from the 53 incidents reported in 2022 with the West Midlands and London being responsible for 44%

and 33% of these incidences, respectively. Therefore, the escalation of infectious diseases is stimulating the CRISPR-based diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20734&type=smp

How Is the CRISPR-Based Diagnostics Market Segmented by Several Divisions?

The CRISPR-based diagnostics market covered in this report is segmented –

1) By Product: Kits, Buffer Solutions, Software, Other Products

2) By Technique: Recombinase Polymerase Amplification (RPA), Loop-mediated Isothermal Amplification (LAMP), Other Techniques

3) By Disease: Infectious Diseases, Non-Infectious Diseases

4) By End-User: Hospitals, Diagnostic Centers, Biotechnology Companies, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits: CRISPR Detection Kits, CRISPR Amplification Kits, CRISPR-Based Assay Kits

2) By Buffer Solutions: CRISPR Reaction Buffers, CRISPR Lysis Buffers

3) By Software: CRISPR Data Analysis Software, CRISPR Design Software, CRISPR Diagnostic Platforms Software

4) By Other Products: CRISPR Enzymes, CRISPR Reagents, CRISPR-Based Probes

What are the Emerging Market Trends Driving the Growth of the CRISPR-Based Diagnostics Industry?

Leading firms in the CRISPR-based diagnostics market such as CrisprBits Private Limited are concentrating on cultivating strategic alliances to boost availability to prompt and precise diagnostics via CRISPR-based point-of-care examinations. These alliances are in the form of long-term collaborations between multiple organizations that pool their resources and know-how to reach a common objective and fortify their market standing. An illustration of this is the partnership announced by CrisprBits Private Limited, a biotechnology firm based in India, with Molbio Diagnostics, an India-based molecular diagnostics firm, in August 2023. This partnership aims at developing CRISPR-based Point-of-Care Tests (POCTs) that offer speedy, accurate, and affordable diagnostic tools using the CRISPR technology to detect pathogens and genetic markers. The goal of these POCTs is to broaden the accessibility of diagnostics in various environments, especially in areas with limited resources, while guaranteeing quick and precise disease identification. This alliance integrates CrisprBits’ proficiency in CRISPR-based platforms and Molbio’s manufacturing and distribution strengths to introduce these tests to a worldwide market.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report

Which Regions Are Driving Growth in the CRISPR-Based Diagnostics Market?

North America was the largest region in the CRISPR-based diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR-based diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20734

This Report Delivers Insight On:

1. How big is the crispr-based diagnostics market, and how is it changing globally?

2. Who are the major companies in the crispr-based diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the crispr-based diagnostics market right now?

4. Which products or customer segments are growing the most in the crispr-based diagnostics market?

5. What factors are helping or slowing down the growth of the crispr-based diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model